Search results
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Careers
At Bristol Myers Squibb, your work helps people prevail over...
- Help Paying for Medicines
In 2015, Bristol Myers Squibb provided more than $694...
- Contact Us
Contact Bristol Myers Squibb through our contact form,...
- About Us
At Bristol Myers Squibb, we work every day to transform...
- Patients & Caregivers
At Bristol Myers Squibb, we are committed to helping you get...
- Investor Relations
Forward-looking statements contained on this website should...
- Events and Presentations
Forward-looking statements contained on this website should...
- Our Company
Bristol Myers Squibb is a global biopharmaceutical company...
- Careers
Bristol Myers Squibb | 1,426,679 (na) tagasubaybay sa LinkedIn. At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the...
Company profile page for Bristol-Myers Squibb Philippines Inc including stock price, company news, executives, board members, and contact information.
Bristol-Myers Squibb Medical Information Online for Philippines. To speak with a Medical Information Professional about one of our products, please contact us at: Email: Medical.enquiries@bms.com. To report an Adverse Event please contact us at: Email: Medical.enquiries@bms.com.
22 hours ago · Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Virtual Targeted Protein Degradation Day hosted by UBS. Robert Plenge, M.D., Ph.D., Executive Vice President, Chief Research Officer and Head of Research, will take part in a fireside chat on Monday, July 15, 2024. He will answer questions about the company beginning at 11:00 a.m. ET. Investors and the ...
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
22 hours ago · PRINCETON, N.J., July 08, 2024--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Virtual Targeted Protein Degradation Day hosted by UBS. Robert Plenge, M.D., Ph.D., Executive Vice President, Chief Research Officer and Head of Research, will take ...